Science Daily (October 22, 2009): Blood Test Shows Promise For Early Diagnosis of Alzheimer's Disease

Publication Date: 
Thu, 10/22/2009

Elderly people exhibiting memory disturbances that do not affect their normal, daily life suffer from a condition called "mild cognitive impairment" (MCI).  Some MCI patients go on to develop Alzheimer's disease within a few years, whereas other cases remain stable,  exhibiting only benign senile forgetfulness. It is crucial to develop simple, blood-based tests enabling early identification of these patients that will progress in order to begin therapy as soon as possible, potentially delaying the onset of dementia.

A group of investigators, led by Professor Massimo Tabaton of the University of Genoa, Italy, have data that sheds light on this issue. The results of their research are published in the October issue of the Journal of Alzheimer's disease.

The investigators report that the concentration in blood of amyloid beta "42," the toxic molecule that is believed to be the main cause of Alzheimer's disease, is, on average, higher in MCI cases that went on to develop Alzheimer's disease approximately three years later.

www.sciencedaily.com/releases/2009/10/091021100754.htm#